3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
27
Breast Neoplasms
23
Neoplasm Metastasis
14
Glioma
14
Carcinoma, Non-Small-Cell Lung
14
Lymphoma
12
Lung Neoplasms
11
Glioblastoma
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
9
Carcinoma, Renal Cell
9
Brain Neoplasms
9
Medulloblastoma
8
Ovarian Neoplasms
7
Neoplasms
7
Multiple Myeloma
7
Ependymoma
7
Carcinoma, Hepatocellular
7
Wilms Tumor
6
Thyroid Neoplasms
6
Sarcoma
6
Rectal Neoplasms
6
Pancreatic Neoplasms
6
Osteosarcoma
6
Melanoma
6
Fallopian Tube Neoplasms
6
Central Nervous System Neoplasms
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Interventions
Mitomycin
9
Gemcitabine
5
apaziquone
3
Docetaxel
2
valrubicin
1
pembrolizumab
1
linrodostat
1
erdafitinib
1
enzalutamide
1
avelumab
1
VB4-845
1
Standard of Care
1
Nivolumab
1
Neoadjuvant Therapy
1
Hyaluronic Acid
1
DDMS
1
BCG Vaccine
1
Administration, Intravesical
1
ALT-801
1
5-aminolevulinic acid hexyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Non-Muscle Invasive Bladder Neoplasms
×
Magnetic Resonance Spectroscopy
×
Clear all
No trials found.